TABLE 3.
Activity of coexpressed recombinant binary ICPs
| Bacterial strain | Binary ICP | LC50 (μg/cm2) | % Mortalitya (highest dosage, in μg/cm2) |
|---|---|---|---|
| MR543 | Cry34Aa1/Cry35Aa1 | 34 (21-130)b | |
| MR544 | Cry34Ab1/Cry35Ab1 | 3 (2-5) | |
| MR546 | Cry34Ac1/Cry35Ac1 | 7 (3-44) | |
| MR561 | Cry34a2B/Cry35Ba2 | NDRc | 55 (110) |
| MR562 | Cry34Ba3/Cry35Ba3 | NDR | 44 (170) |
| MR529 (negative control) | None | NDR |
a
The effects of treatments for which the 50% lethal concentration (LC50) could not be calculated are expressed in percent mortality at the top dose.
b
95% Confidence interval values are in parentheses.
c
NDR, dose response could not be calculated.